Results 261 to 270 of about 73,703 (332)

Cost‐Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions

open access: yesAllergy, EarlyView.
This study evaluates the cost‐effectiveness of Hymenoptera venom depot immunotherapy (HVDI) with Alutard SQ compared to adrenaline auto‐injectors (AAIs) in Denmark. The model incorporates both psychological and physiological benefits to estimate quality‐adjusted life years (QALYs).
Gunter Sturm   +6 more
wiley   +1 more source

QALY-Changes in Finland 1995/96-2004

open access: green, 2007
Timo Seppαlä   +2 more
openalex   +1 more source

Corneal power modelling with OCT data – Thin and thick lens paraxial models versus raytracing

open access: yesActa Ophthalmologica, EarlyView.
Abstract Background Evaluating keratometric power with Zeiss index (PKZ), paraxial thick cornea power (Gullstrand [PG]) and power referenced to the front (PFV) and back vertex plane (PBV) and raytracing power (PR), and modelling the deviation from PKZ with a multivariable linear prediction model.
Achim Langenbucher   +4 more
wiley   +1 more source

Cost-effectiveness Analysis Comparing Osia System to Percutaneous Bone Conduction Devices in Sweden. [PDF]

open access: yesOtol Neurotol
Ghinelli F   +6 more
europepmc   +1 more source

Tick‐Borne Encephalitis (TBE) Vaccine in the National Immunisation Programme—For Whom, When and Where?

open access: yesActa Paediatrica, EarlyView.
ABSTRACT The incidence of Tick‐borne encephalitis (TBE) cases has increased. The presumed location of transmission of Tick‐borne encephalitis virus (TBEV) has been expanding increasingly in the western parts of Europe during the past decade. There has also been an increased incidence of surveillance‐reported TBE cases in southern Sweden and southern ...
H. H. Askling, D. Zavadska
wiley   +1 more source

Cost-effectiveness analysis of artificial intelligence (AI) for response prediction of neoadjuvant radio(chemo)therapy in locally advanced rectal cancer (LARC) in the Netherlands. [PDF]

open access: yesExpert Rev Pharmacoecon Outcomes Res
Maas L   +16 more
europepmc   +1 more source

Cost–benefit analysis and ‘next best’ methods to evaluate the efficiency of social policies: As in pitching horseshoes, closeness matters

open access: yesAnnals of Public and Cooperative Economics, EarlyView.
Abstract Many policymakers are unwilling, or think that it is infeasible, to perform comprehensive cost–benefit analysis (CBA) of programmes in social policy arenas. What principles actually underlie CBA? An understanding is necessary to assess whether other evaluation methods are close enough to CBA to provide useful information on social efficiency ...
Aidan R. Vining, Anthony E. Boardman
wiley   +1 more source

Home - About - Disclaimer - Privacy